help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishimura, A.
Right arrow Articles by Suda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishimura, A.
Right arrow Articles by Suda, T.

Endocrinology, Vol 134, 1794-1799, Copyright © 1994 by Endocrine Society


ARTICLES

Regulation of messenger ribonucleic acid expression of 1 alpha,25- dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts

A Nishimura, T Shinki, CH Jin, Y Ohyama, M Noshiro, K Okuda and T Suda
Department of Biochemistry, School of Dentistry, Showa University, Tokyo, Japan.

We have reported that PTH inhibits 25-hydroxyvitamin D3-24-hydroxylase messenger RNA (mRNA) expression induced by 1 alpha,25-dihydroxyvitamin D3 [1 alpha, 25-(OH)2D3] in rat kidney but not intestine. In the present study, we examined whether the suppression of 24-hydroxylase mRNA expression by PTH occurs commonly in tissues and cells which have PTH receptors. Administration of 1 alpha, 25-(OH)2D3 into rats fed a synthetic vitamin D-repleted diet containing adequate calcium greatly increased serum levels of calcium and 1 alpha, 25-(OH)2D3. Also, there was a 4-fold increase in bone 24-hydroxylase activity in response to 1 alpha, 25-(OH)2D3 administration. In rats fed a low calcium diet, renal 24-hydroxylase activity was suppressed probably due to secondary hyperparathyroidism. In contrast, the low calcium feeding did not suppress bone 24-hydroxylase activity. The expression of 24-hydroxylase mRNA in rat osteoblastic C-26 and C-11 cells was similar and attained maximal levels 24 h after cells were incubated with 10(-8) M 1 alpha, 25-(OH)2D3. Induction of 24-hydroxylase mRNA expression by 1 alpha, 25- (OH)2D3 was much greater and earlier in immature C-26 cells than mature C-11 cells. Simultaneous addition of PTH, prostaglandin E2, or cAMP together with 1 alpha, 25-(OH)2D3 did not down-regulate mRNA expression of 24-hydroxylase induced by the vitamin in both C-26 and C-11 cells. Of the three osteoblastic cells (C-26, C-20, and C-11) examined, C-26 cells showed the least mRNA expression of vitamin D receptors, in spite of the highest expression of 24-hydroxylase mRNA. These results suggest that unlike in the kidney, bone 24-hydroxylase mRNA expression is not down-regulated by PTH despite of the presence of PTH receptors. They also suggest that the degree of the induction of 24-hydroxylase mRNA by 1 alpha, 25-(OH)2D3 is not explained simply by the vitamin D receptors content.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Cui and T. E. Rohan
Vitamin d, calcium, and breast cancer risk: a review.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1427 - 1437.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-M. Nguyen, M. Lieberherr, J. Fritsch, H. Guillozo, M. L. Alvarez, Z. Fitouri, F. Jehan, and M. Garabedian
The Rapid Effects of 1,25-Dihydroxyvitamin D3 Require the Vitamin D Receptor and Influence 24-Hydroxylase Activity: STUDIES IN HUMAN SKIN FIBROBLASTS BEARING VITAMIN D RECEPTOR MUTATIONS
J. Biol. Chem., February 27, 2004; 279(9): 7591 - 7597.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. St-Arnaud and F. H. Glorieux
Editorial: 24, 25-Dihydroxyvitamin D--Active Metabolite or Inactive Catabolite?
Endocrinology, August 1, 1998; 139(8): 3371 - 3374.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A.S. Dusso, S. Kamimura, M. Gallieni, M. Zhong, L. Negrea, S. Shapiro, and E. Slatopolsky
{gamma}-Interferon-Induced Resistance to 1,25-(OH)2 D3 in Human Monocytes and Macrophages: A Mechanism for the Hypercalcemia of Various Granulomatoses
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2222 - 2232.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Akeno, S. Saikatsu, T. Kawane, and N. Horiuchi
Mouse Vitamin D-24-Hydroxylase: Molecular Cloning, Tissue Distribution, and Transcriptional Regulation by 1{alpha},25-Dihydroxyvitamin D3
Endocrinology, June 1, 1997; 138(6): 2233 - 2240.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Miyamoto, T. Shinki, K. Yamamoto, Y. Ohyama, H. Iwasaki, R. Hosotani, T. Kasama, H. Takayama, S. Yamada, and T. Suda
1alpha ,25-Dihydroxyvitamin D3-24-Hydroxylase (CYP24) Hydroxylates the Carbon at the End of the Side Chain (C-26) of the C-24-fluorinated Analog of 1alpha ,25-Dihydroxyvitamin D3
J. Biol. Chem., May 30, 1997; 272(22): 14115 - 14119.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Ohyama, K. Ozono, M. Uchida, M. Yoshimura, T. Shinki, T. Suda, and O. Yamamoto
Functional Assessment of Two Vitamin D-responsive Elements in the Rat 25-Hydroxyvitamin D3 24-Hydroxylase Gene
J. Biol. Chem., November 29, 1996; 271(48): 30381 - 30385.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Kerry, P. P. Dwivedi, C. N. Hahn, H. A. Morris, J. L. Omdahl, and B. K. May
Transcriptional Synergism between Vitamin D-responsive Elements in the Rat 25-Hydroxyvitamin D3 24-Hydroxylase (CYP24) Promoter
J. Biol. Chem., November 22, 1996; 271(47): 29715 - 29721.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society